Board of Directors

Our PCN’s Board of Directors consists of doctors in our membership and members of the public. They provide strategic and budgetary oversight for the CWC PCN. 

During the 2025-26 fiscal year, we welcomed one new Board member and completed a planned leadership transition, with the previous Vice-Chair assuming the role of Board Chair. This transition supported continuity in governance leadership during a period of change.  

Throughout the year, our Board remained focused on organizational stability and strong governance in anticipation of changes to Alberta’s primary care landscape and ongoing health system regionalization. Our Board continued to monitor organizational performance and strategic priorities, including advancing work on the Key Performance Indicator (KPI) Dashboard to strengthen oversight and support informed decision-making. 

As part of the 2025-26 Board Self-Improvement Action Plan, the Board Policy & Human Resources Committee is engaging with our PCN’s administrative Diversity, Equity, Inclusion, and Belonging (DEIB) Steering Committee to establish a Board-endorsed DEIB statement.  

Your 2025-26 Board members

  • Amanda Wang,
    Chair
  • Tim Rose,
    External Director,
    Treasurer
  • Mileva Stojanovic,
    Director
  • Robin Prashad,
    External Director
  • Jenny Mazuryk,
    Joint Venture Governance Rep
  • Vincent Vong,
    Past-Chair
  • Antony Ng,
    Director
  • Sameena Khan,
    Director
  • Michael Yosefi,
    Director
  • Ashley Humeniuk,
    Vice-Chair
  • Jennifer Bikow,
    Director
  • Mike Spady,
    Joint Venture Governance Rep
  • Karen Sharp,
    External Director
  • Lesley Myles,
    Joint Venture Governance Rep
  • Christopher Cameron,
    Executive Director,
    Ex-Officio

Board committees

The Board’s four subcommittees provide additional guidance for the CWC PCN.

Board Development Committee
Finance Audit and Risk Committee
Membership and External
Relations Committee
Board Policy and Human
Resources Committee

Continuity, support,
and stability

To ensure continuity and effective governance support, operational responsibilities were realigned during the year following changes within the Governance & Organizational Operations team. Governance functions were consolidated within the Human Resources portfolio under the Director of Human Resources & Corporate Governance, including oversight of Board governance, policies, risk management, and privacy, as well as the administration of the Patient Advisory Council (PAC).  

The Corporate Governance team continued to advance the organization’s Enterprise Risk Management (ERM) program in alignment with the Risk Intelligence Committee. This work included implementing an updated ERM Framework and Risk Management policy, as well as ongoing monitoring of enterprise risks to support proactive planning during a period of system change. To further strengthen oversight, they developed a new Risk Report, which is regularly shared with the Finance, Audit & Risk Committee, and the Board. This report provides visibility into ERM activities and highlights key risks that require Board-level oversight, in alignment with internal policies. 

Strengthened policy and
governance framework

The Policy team undertook a comprehensive review of organizational policies in 2025, revising a total of 45 policy documents across key areas, including patient safety, Human Resources, and privacy. These updates ensure alignment with current legislation, regulatory requirements, and evolving organizational practices.

In addition, our PCN introduced a new Artificial Intelligence policy to guide the responsible and appropriate use of AI technologies in the workplace. This policy supports innovation while ensuring compliance, privacy, and ethical use of emerging technologies.